These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21903392)

  • 21. Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities.
    Macaev F; Rusu G; Pogrebnoi S; Gudima A; Stingaci E; Vlad L; Shvets N; Kandemirli F; Dimoglo A; Reynolds R
    Bioorg Med Chem; 2005 Aug; 13(16):4842-50. PubMed ID: 15993090
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinonoid and phenazine compounds: synthesis and evaluation against H37Rv, rifampicin and isoniazid-resistance strains of Mycobacterium tuberculosis.
    Carneiro PF; Pinto Mdo C; Coelho TS; Cavalcanti BC; Pessoa C; de Simone CA; Nunes IK; de Oliveira NM; de Almeida RG; Pinto AV; de Moura KC; da Silva PA; da Silva Júnior EN
    Eur J Med Chem; 2011 Sep; 46(9):4521-9. PubMed ID: 21820768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
    Woodley CL; Kilburn JO
    Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
    Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
    Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis.
    Heifets LB; Lindholm-Levy PJ; Iseman MD
    Am Rev Respir Dis; 1988 Mar; 137(3):719-21. PubMed ID: 2830815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clubbed [1,2,3] triazoles by fluorine benzimidazole: a novel approach to H37Rv inhibitors as a potential treatment for tuberculosis.
    Gill C; Jadhav G; Shaikh M; Kale R; Ghawalkar A; Nagargoje D; Shiradkar M
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6244-7. PubMed ID: 18930654
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].
    Saito H; Sato K; Tomioka H
    Kekkaku; 1988 Mar; 63(3):167-72. PubMed ID: 2836649
    [No Abstract]   [Full Text] [Related]  

  • 28. Substituted hydrazinecarbothioamide as potent antitubercular agents: synthesis and quantitative structure-activity relationship (QSAR).
    Singh S; Mandal PK; Singh N; Misra AK; Singh S; Chaturvedi V; Sinha S; Saxena AK
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2597-600. PubMed ID: 20304645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pyrazole derivatives from azines of substituted phenacyl aryl/cyclohexyl sulfides and their antimycobacterial activity.
    Manikannan R; Venkatesan R; Muthusubramanian S; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2010 Dec; 20(23):6920-4. PubMed ID: 20970331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of substituted 4,6-diarylpyrimidines and 3,5-diphenyl-4,5-dihydro-1H-pyrazoles as anti-tubercular agents.
    Pathak V; Maurya HK; Sharma S; Srivastava KK; Gupta A
    Bioorg Med Chem Lett; 2014 Jul; 24(13):2892-6. PubMed ID: 24835631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3'-bromo analogues of pyrimidine nucleosides as a new class of potent inhibitors of Mycobacterium tuberculosis.
    Shakya N; Srivastav NC; Desroches N; Agrawal B; Kunimoto DY; Kumar R
    J Med Chem; 2010 May; 53(10):4130-40. PubMed ID: 20420370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and in vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing lipophilic carbamoyl group.
    Yadlapalli RK; Chourasia OP; Vemuri K; Sritharan M; Perali RS
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2708-11. PubMed ID: 22437116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid speciation of 15 clinically relevant mycobacteria with simultaneous detection of resistance to rifampin, isoniazid, and streptomycin in Mycobacterium tuberculosis complex.
    Shenai S; Rodrigues C; Mehta A
    Int J Infect Dis; 2009 Jan; 13(1):46-58. PubMed ID: 18565777
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of SQ109 analogues as potential anti-tuberculosis candidates.
    Onajole OK; Govender P; van Helden PD; Kruger HG; Maguire GE; Wiid I; Govender T
    Eur J Med Chem; 2010 May; 45(5):2075-9. PubMed ID: 20149497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Green synthesis and anti-infective activities of fluorinated pyrazoline derivatives.
    Shelke SN; Mhaske GR; Bonifácio VD; Gawande MB
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5727-30. PubMed ID: 22832312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and structure-activity relationships of antitubercular 2-nitroimidazooxazines bearing heterocyclic side chains.
    Sutherland HS; Blaser A; Kmentova I; Franzblau SG; Wan B; Wang Y; Ma Z; Palmer BD; Denny WA; Thompson AM
    J Med Chem; 2010 Jan; 53(2):855-66. PubMed ID: 19968290
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis.
    Kurabachew M; Lu SH; Krastel P; Schmitt EK; Suresh BL; Goh A; Knox JE; Ma NL; Jiricek J; Beer D; Cynamon M; Petersen F; Dartois V; Keller T; Dick T; Sambandamurthy VK
    J Antimicrob Chemother; 2008 Oct; 62(4):713-9. PubMed ID: 18587134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design, synthesis and antimycobacterial activity of some novel imidazo[1,2-c]pyrimidines.
    Chhabria MT; Jani MH
    Eur J Med Chem; 2009 Oct; 44(10):3837-44. PubMed ID: 19423196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel dihydropyrimidines as a potential new class of antitubercular agents.
    Trivedi AR; Bhuva VR; Dholariya BH; Dodiya DK; Kataria VB; Shah VH
    Bioorg Med Chem Lett; 2010 Oct; 20(20):6100-2. PubMed ID: 20813528
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.